News | April 13, 2026
Unichem’s US arm recalls Buspirone tablets after stability test OOS result
No adverse events reported; recall involves 5 mg 500-count bottles in the US market
No adverse events reported; recall involves 5 mg 500-count bottles in the US market
The approval now covers procedures using 10-14F inner diameter and up to 17F outer diameter procedural sheaths
The once-daily oral medication is approved for adults with obesity or overweight who have weight-related medical conditions
The approval clears the way for a US study at leading clinical centers to evaluate the safety and effectiveness of VDYNE’s system in patients
The study is a global, randomized, double-blind, placebo-controlled trial testing GLM101 for phosphomannomutase 2 congenital disorder of glycosylation
The new single-pill therapy combines cilnidipine, telmisartan and metoprolol, bringing together three established antihypertensive agents with complementary mechanisms
The new device promises faster, more efficient cardiac procedures while maintaining the safety and effectiveness clinicians expect
For the biopharma industry, the study strengthens the case for balancing immune-cell engagement with tolerability in antibody discovery platforms
36 districts to get advanced ALS, BLS and neonatal ambulances under MEMS 108
Surgeon Yuvaraja operates on a 55-year-old patient at Medical City Hospital Muscat
Subscribe To Our Newsletter & Stay Updated
